Effect of esketamine nasal drops on pain in children after tonsillectomy using low temperature plasma ablation

被引：3
作者：
Qian, Qiu [1 ]
Liu, Hua Xian [2 ]
Li, Yue Qing [2 ]
机构：
[1] Suzhou Wujiang Dist Childrens Hosp, Dept Anesthesiol, Suzhou, Peoples R China
[2] Soochow Univ, Dept Anesthesiol, Childrens Hosp, Suzhou, Peoples R China
来源：
FRONTIERS IN PEDIATRICS | 2023年 / 11卷
关键词：
children; esketamine nasal drops; low temperature plasma ablation; tonsillar hypertrophy; tonsillectomy;
D O I：
10.3389/fped.2023.1110632
中图分类号：
R72 [儿科学];
学科分类号：
100202 ;
摘要：
ObjectiveTo explore the effect of esketamine nasal drops on pain in children after tonsillectomy using low-temperature plasma ablation. Methods76 children who underwent tonsillectomy between May 2020 and July 2021, were randomly divided into two groups of 38 cases each. Patients in the control group were treated with conventional medication, while those in the study group were treated with esketamine nasal drops, along with the routine drug treatment. Pain levels of children in the two groups were compared within 1-3 days post-surgery, and the pseudomembrane formation and shedding-off time and recovery time were statistically analyzed. ResultsThe pain level of children in the study group was lower than that of the control group 1-3 days post-surgery. The pseudomembrane formation and shedding-off time and recovery time in the study group were shorter than in the control group (P < 0.05). There was no significant difference in the incidence of adverse reactions between the two groups, and there were no serious adverse reactions in the two groups (P > 0.05). ConclusionIt is safe to use esketamine nasal drops in children after tonsillectomy using low temperature plasma ablation, and this is found to reduce pain and shorten the recovery time.
引用
收藏
页数：4
相关论文
共 25 条
  • [1] Adult sleep apnea and tonsil hypertrophy: should pharyngoplasty be associated with tonsillectomy?
    Baudouin, Robin
    Blumen, Marc
    Chaufton, Cyril
    Chabolle, Frederic
    [J]. SLEEP AND BREATHING, 2019, 23 (03) : 917 - 923
  • [2] Chen FM., 2019, CHINA FOREIGN MED TR, V38, P116
  • [3] Chen L., 2019, CHINA CONTINUING MED, V11, P77
  • [4] Chen Z., 2019, J CLIN PSYCHIAT, V29, P426
  • [5] Gu Y., 2017, CHONGQING MED, V46, P3, DOI [10.3969/j.issn.1671-8348.2017.12.035, DOI 10.3969/J.ISSN.1671-8348.2017.12.035]
  • [6] Guo Y., 2018, CHINA MED HERALD, V15, P111
  • [7] Guo Y., 2021, CHINA MED REV, V18, P4
  • [8] Hao Y., 2019, SHANXI MED J, V48, P3
  • [9] Jiang SM., 2019, CHIN J GEN PRACT, V17, P966, DOI [10.16766/j.cnki.issn.1674-4152.000837, DOI 10.16766/J.CNKI.ISSN.1674-4152.000837]
  • [10] Jing JJ, 2020, J BUON, V25, P2382
123